INTRODUCTION
Entamoeba moshkovskii cysts and trophozoites are not easily distinguished from those of the nonpathogenic E. dispar and the diseasecausing E. histolytica and can therefore confound interpretation of stool microscopy. [1] "Entamoeba moshkovskii is primarily described as a free-living amoeba that rarely infects humans". [2] A high incidence of E. moshkovskii infections was reported in humans from Bangladesh, [1] India, [3] Turkey, [4] Australia [5] and Cameroon, [6] but to the best of our knowledge, the infection has not been reported in Kaduna State, Nigeria.
The morphological similarity of E. moshkovskii and E. dispar to disease-causing E. histolytica makes it important to differentiate the three species by polymerase chain reaction (PCR). In the clinical setting, this may lead to a misdiagnosis and unnecessary treatment with anti-amoebic chemotherapy. [7] This study reports the first molecular identification of E. moshkovskii in Kaduna State, Nigeria. We used microscopy, polymerase chain reaction (PCR) and DNA sequencing to detect and differentiate E. moshkovskii, E. dispar and E. histolytica in stool samples from diarrhoeic patients in Kaduna State, Nigeria. Eighty eight (88) stool samples were collected from each of the six selected hospitals, totaling 528 stool samples collected from January, 2013 to December 2015. Iodine wet mounts of fresh unpreserved faecal samples were examined microscopically for demonstrating cysts and trophozoites of Entamoeba species complex as described by Cheesbrough. [8] Briefly, a small fraction of feces was mixed with a small drop of Lugols iodine (diluted 1: 5 with water) on a microscope slide, and observed under microscope after placing a cover slip over the preparation.
METHODOLOGY
The DNA extraction of all microscopy-positive samples was carried out using the MagNa Pure DNA isolation kit (Roche Applied Sciences) according to the manufacturer's instruction. Primary PCR for the detection of Entamoeba genus used forward primer E-1 (5'-TAAGATGCA GAGCGAAA-3') and reverse primer E-2 (5'-GTACAAAGGGCAGGGACGTA-3') and secondary nested set Mos-1 (5'-GAA ACC AAG AGT TTC ACA AC-3') and Mos-2 (5'-CAA TAT AAG GCT TGG ATG AT-3') to detect E. moshkovskii (553 bp) was carried out as described by Khaimar and Parija.
[9] Entamoeba species genomic DNA (positive control) was included in each PCR run. "The PCR products were also sequenced using an ABI Prism 377 DNA sequencer (Applied Bio system)". [9] The 16S rRNA gene sequences obtained were compared with those available in the GenBank database with the BLASTn program run on the http:// www.ncbi.nlm.nih.gov/BLAST.
RESULTS
Out of the 46 microscopy positive samples, 16 (34.8%) successfully amplified Entamoeba species DNA. Of the 16 PCR positive results, Entamoeba dispar infection 11 (68.8%) was the most prevalent, followed by Entamoeba histolytica 6 (37.5%) and Entamoeba moshkovskii 3 (18.8%). Mixed infection with Entamoeba moshkovskii and Entamoeba dispar was seen in 2 (12.5%) samples, while only 1 (6.3%) sample had only Entamoeba moshkovskii mono infection. [10] The sequences of the three identified E. moshkovskii isolates in Figure 1 showed 98% similarity to seven E. moshkovskii sequences deposited in the GenBank (for example, KP722600.1).
DISCUSSION
The findings of the present study revealed for the first time the presence of E. moshkovskii in Kaduna State, Nigeria. Similar cases of humans infected with Entamoeba moshkovskii have been reported sporadically in different parts of the world including Bangladesh, [1] India, [3[ Australia, [5] and Cameroon. [6] In clinical practice, the distinction of such infectious protozoan from the morphologically similar E. histolytica and E. dispar would avoid a misdiagnosis and unnecessary management with anti-amoebic drugs. The observed symptoms of diarrhoea or dysentery in the individuals infected with E. moshkovskii in this study, suggest that it could be a potential pathogen for humans as reported by many authors. [5, 11] The co-infection of E. moshkovskii and E. dispar also agreed with previous reports from different parts of the world. [3, 4, 12] The co-infections could be explained by the identical patterns of human contamination of these infectious intestinal amoebae. [13] The high degree in similarity (99%) of Entamoeba moshkovskii ribosomal RNA gene sequenced to the Entamoeba moshkovskii sequences in GenBank (such as accession no. KP722605.1) confirmed the DNAs amplified as being of Entamoeba moshkovskii origin. We could not able to use PCR to amplify genomic DNA from some samples that were positive for Entamoeba complex by microscopy with the primer used despite the absence of inhibitors. These results can potentially be explained by the presence of another Entamoeba species, genetically distinct but identical in microscopic appearance to the small cysts of E. coli or the large cysts of E. Hartman, [11] or it could be due to complexities associated with faecal samples for direct PCR testing because of the presence of PCR inhibitors, such as heme, bilirubins, bile salts, and complex carbohydrates, which are often correlated along with pathogen DNA. [5] 
CONCLUSION
To the best of our knowledge, this is the first report of E. moshkovskii infection from Kaduna State, Nigeria. Although most reports support the commensal nature of E. moshkovskii, this report however, agrees with Fotedar and coworkers, [5] that it may be pathogenic. We recommend the use of molecular techniques in the diagnosis of amoebiasis and further studies should be carried out to establish the causal link between the presence of E. moshkovskii and the symptoms of the disease.
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